What is Alodokter?
Founded in 2014, Alodokter has established itself as a leading telemedicine platform, offering a comprehensive suite of healthcare software services. The company's mission is to enhance access to quality healthcare through innovative digital solutions, connecting patients with medical professionals and providing essential health information. Its operations are centered in Jakarta, Indonesia, a key market for digital health adoption in Southeast Asia. The company's consistent ability to attract substantial investment highlights its strong market position and the growing demand for accessible, technology-driven healthcare services.
How much funding has Alodokter raised?
Alodokter has raised a total of $42.5M across 3 funding rounds:
Series A
$2.5M
Series B
$7M
Series C
$33M
Series A (2016): $2.5M with participation from 500.com and Golden Gate Ventures
Series B (2017): $7M led by SoftBank Corp
Series C (2020): $33M supported by Hera Capital, Dayli Partners, Sequis Life, Golden Gate Ventures, MDI Ventures, Softbank Ventures Asia, Philips, and Heritas
Key Investors in Alodokter
500.com
500.com Limited is a leading online sports lottery service provider in China, offering integrated online lottery services. While their primary focus is lottery services, their participation suggests an interest in digital platforms and potentially diversified investment strategies.
Golden Gate Ventures
Golden Gate Ventures is a venture capital firm specializing in early-stage investments across Southeast Asia, focusing on high-growth sectors like consumer internet and digital media. Their investment in Alodokter aligns with their strategy of backing innovative tech startups in the region.
SoftBank Corp
SoftBank Group Corp. is a global technology holding company investing in telecommunications, internet services, and AI. Their backing of Alodokter indicates a strategic interest in the burgeoning digital health and telemedicine market in Southeast Asia.
What's next for Alodokter?
The substantial enterprise-level funding Alodokter has garnered signals a strategic phase of scaling and expansion. With a clear focus on enhancing its telemedicine capabilities and potentially broadening its service offerings, the company is well-positioned to capitalize on the increasing digital transformation within the healthcare sector. Future developments are likely to involve further technological integration, expanding its network of healthcare providers, and deepening its market penetration across Indonesia and potentially other Southeast Asian markets. The sustained investor confidence suggests a promising outlook for continued innovation and growth in the digital health landscape.
See full Alodokter company page
